advertisement
Multiple Myeloma News
September 26, 2020

Top Headlines
 

Latest Headlines
updated 9:27am EDT

Earlier Headlines
 

Lenalidomide May Delay Onset of Myeloma-Related Bone, Organ Damage

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ ...

Cardiac Toxicity Risk Factors Identified With Relapsed Multiple Myeloma Therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study. The study recommends that ...

Rare Cancer Could Be Caught Early Using Simple Blood Tests

A pioneering study into myeloma, a rare cancer, could lead to GPs using simple blood tests to improve early ...

Looking at the Urine and Blood May Be Best in Diagnosing Myeloma

When it comes to diagnosing a condition in which the plasma cells that normally make antibodies to protect us instead become cancerous, it may be better to look at the urine as well as the serum of ...

Crystal Structure Reveals How Curcumin Impairs Cancer

Through x-ray crystallography and kinase-inhibitor specificity profiling, researchers reveal that curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase ...

Blood Cancer Precursor Found in 9/11 Firefighters

A new study reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead to the ...

Chip-Based Blood Test for Multiple Myeloma Could Make Bone Biopsies a Relic of the Past

A new research effort has resulted in a low-cost, reliable blood test that uses a small plastic chip about the size of a credit card that can deliver the same diagnostic information as a bone biopsy ...

Changes in Genes Involved in DNA Repair and Packaging Linked to Risk of Multiple Myeloma

Researchers have identified two gene regions that contribute to multiple myeloma, an inherited cancer that occurs in bone marrow, through a new method that makes use of human disease ...

Light-Triggered Nanoparticles Show Promise Against Metastatic Cancer

A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -- which is limited to the skin and areas accessible with an endoscope -- this technique can target and ...

Patients With Blood Cancer Precursor at Risk of Developing Cancer Even After 30 Years

Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer even after 30 years of ...

Carfilzomib Can Lead to Cardiovascular Toxicity in Multiple Myeloma Patients

The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research shows the therapy comes with the risk of cardiovascular problems in a ...

CT Scans of Egyptian Mummies Reveal Oldest Known Cases of Breast Cancer and Multiple Myeloma

An international team has discovered the world's oldest known cases of breast cancer and multiple myeloma (a type of bone marrow cancer). The discoveries were made by conducting CT scans of two ...

In Multiple Myeloma, High Levels of Enzyme ADAR1 Are Associated With Reduced Survival

Using a database of multiple myeloma patient samples and information, researchers found that high ADAR1 levels correlate with reduced survival rates. They also determined that blocking the enzyme ...

One-Size Treatment for Blood Cancer Probably Doesn't Fit All, Researchers Say

Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European ...

Cell-Weighing Method Could Help Doctors Choose Cancer Drugs

Researchers can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple myeloma patients. Their predictions correlated with how those patients actually fared ...